IMMUNOLOGY QUALITY ASSESSMENT PROGRAM

免疫学质量评估计划（IQA）的目的是继续并提供资源，以（1）评估美国和非美国实验室准确可靠地进行研究规定的免疫学检测的能力（重点是CD4和CD8 T细胞淋巴细胞计数和百分比）和活PBMC冷冻，（2）在发现缺陷时提供建议和培训，（3）评估基于免疫学的新技术（重点是用于诊断和疾病监测的新的、简单的测试），以在多中心NIAID试验中实施，以及（4）维护计算机化的数据管理系统和文件库，包括实验室性能数据和指导文件。IQA将继续支持目前和未来NIAID赞助的临床试验网络的实验室

The purpose of the Immunology Quality Assessment Program (IQA) is to continue and provide a resource to (1) evaluate the abilities of U.S. and non-U.S. laboratories to accurately and reliably perform study-specified immunological tests (with focus on CD4 and CD8 T cell lymphocyte counts and percentages) and viable PBMC freezing, (2) advise and train when deficiencies are identified, (3) evaluate immunology-based novel technologies (with focus on novel, simple tests for diagnosis and disease monitoring) for implementation in multi-site NIAID trials, and (4) maintain a computerized data management system and document library that include lab performance data and guidance documents. IQA will continue to support laboratories that are part of current and future NIAID-sponsored clinical trial networks